GL1X · GenesisL1 explorer

Research workbench

One active site, two modes of reduction correlate the mechanism of leishmania pteridine reductase with pterin metabolism and antifolate drug resistance in trpanosomes

Analyse One active site, two modes of reduction correlate the mechanism of leishmania… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1E7W
Type
protein
Length
525 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pteridine reductase
EC
1.1.1.253
UniProt
Q9U1F8
Ligands
NDP, MTX
Pockets
5 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APteridine reductase (EC 1.1.1.253)protein26748% helix, 15% strandQ9U1F8
BPteridine reductase (EC 1.1.1.253)protein25848% helix, 17% strandQ9U1F8

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B
  • MTX · Methotrexate · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15990.730.8048NDP, MTX, EDO
25870.720.8048NDP, MTX, EDO
32340.580.7931empty
4690.350.7822EDO
5500.260.7415empty

Interfaces

1 interface between chains.

  • A–B · 1898 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 1E7W · One active site, two modes of reduction correlate the mechanism of leishmania pteridine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.